Stay updated on IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial

Sign up to get notified when there's something new on the IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays software revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T15:42:43.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH website changes and says that “Super Intelligence” (SI) is replacing “Artificial Intelligence” (AI) in some agency content during the transition.
    Difference
    0.8%
    Check dated 2026-10-25T14:40:03.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T14:43:00.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site's displayed revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T14:55:42.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    New revision v3.7.0 was added to the Study Record History, and the previous revision v3.6.6 was removed, reflecting an administrative update to the trial's documentation.
    Difference
    0.1%
    Check dated 2026-09-20T19:45:03.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry for v3.6.6. The previous revision entry for v3.6.5 has been removed from the history.
    Difference
    0.1%
    Check dated 2026-08-30T08:12:49.000Z thumbnail image

Stay in the know with updates to IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial page.